Annual CFF
$0.00
-$8000.00-100.00%
31 December 2023
Summary:
Zomedica annual cash flow from financing activities is currently $0.00, with the most recent change of -$8000.00 (-100.00%) on 31 December 2023. During the last 3 years, it has fallen by -$76.71 million (-100.00%). ZOM annual CFF is now -100.00% below its all-time high of $219.16 million, reached on 31 December 2021.ZOM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$70.00 K
0.00%
30 September 2024
Summary:
Zomedica quarterly cash flow from financing activities is currently -$70.00 thousandOver the past year, it has dropped by -$70.00 thousand (-100.00%). ZOM quarterly CFF is now -100.03% below its all-time high of $217.27 million, reached on 31 March 2021.ZOM Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
-$70.00 K
0.00%
30 September 2024
Summary:
Zomedica TTM cash flow from financing activities is currently -$70.00 thousandOver the past year, it has dropped by -$70.00 thousand (-100.00%). ZOM TTM CFF is now -100.02% below its all-time high of $291.83 million, reached on 31 March 2021.ZOM TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZOM Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -100.0% | -100.0% | -100.0% |
| 3 y3 years | -100.0% | -117.5% | -100.0% |
| 5 y5 years | -100.0% | -4900.0% | -100.3% |
ZOM Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -100.0% | -117.5% | at low | -100.0% | at low | |
| 5 y | 5 years | -100.0% | -100.0% | +13.6% | -100.0% | at low | |
| alltime | all time | -100.0% | -100.0% | +13.6% | -100.0% | at low |
Zomedica Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$70.00 K(<-9900.0%) | -$70.00 K(<-9900.0%) |
| Dec 2023 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2023 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2022 | $8000.00(-100.0%) | $0.00(-100.0%) | $8000.00(-74.2%) |
| Sept 2022 | - | $8000.00(-65.2%) | $31.00 K(-100.0%) |
| Dec 2021 | $219.16 M(+185.7%) | $23.00 K(-94.3%) | $219.16 M(-5.4%) |
| Sept 2021 | - | $400.00 K(-72.8%) | $231.78 M(-10.8%) |
| June 2021 | - | $1.47 M(-99.3%) | $259.97 M(-10.9%) |
| Mar 2021 | - | $217.27 M(+1618.4%) | $291.83 M(+280.4%) |
| Dec 2020 | $76.71 M(+415.2%) | $12.64 M(-55.8%) | $76.71 M(+19.9%) |
| Sept 2020 | - | $28.59 M(-14.2%) | $63.99 M(+80.8%) |
| June 2020 | - | $33.33 M(+1448.8%) | $35.40 M(+152.2%) |
| Mar 2020 | - | $2.15 M(-2756.5%) | $14.04 M(-5.7%) |
| Dec 2019 | $14.89 M(+45.2%) | -$81.00 K(+5685.7%) | $14.89 M(-24.5%) |
| Sept 2019 | - | -$1400.00(-100.0%) | $19.73 M(-0.4%) |
| June 2019 | - | $11.97 M(+298.0%) | $19.82 M(+67.1%) |
| Mar 2019 | - | $3.01 M(-36.8%) | $11.86 M(+15.6%) |
| Dec 2018 | $10.26 M | $4.76 M(+5403.8%) | $10.26 M(+60.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | $86.40 K(-97.8%) | $6.38 M(-33.9%) |
| June 2018 | - | $4.01 M(+184.8%) | $9.65 M(+11.7%) |
| Mar 2018 | - | $1.41 M(+60.7%) | $8.64 M(+15.4%) |
| Dec 2017 | $7.49 M(+56.4%) | $876.10 K(-73.9%) | $7.49 M(+13.3%) |
| Sept 2017 | - | $3.36 M(+12.2%) | $6.61 M(+103.5%) |
| June 2017 | - | $3.00 M(+1091.2%) | $3.25 M(+1191.2%) |
| Mar 2017 | - | $251.60 K(>+9900.0%) | $251.60 K(>+9900.0%) |
| Dec 2016 | $4.79 M(+12.2%) | - | - |
| Dec 2015 | $4.27 M(+2074.7%) | - | - |
| Nov 2015 | - | $0.00(0.0%) | $0.00(0.0%) |
| Aug 2015 | - | $0.00(0.0%) | $0.00(0.0%) |
| May 2015 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Nov 2014 | - | $0.00(0.0%) | -$9400.00(-104.8%) |
| Aug 2014 | - | $0.00(0.0%) | $196.30 K(0.0%) |
| May 2014 | - | $0.00(-100.0%) | $196.30 K(0.0%) |
| Feb 2014 | $196.20 K | -$9400.00(-104.6%) | $196.30 K(-4.6%) |
| Nov 2013 | - | $205.70 K(>+9900.0%) | $205.70 K(>+9900.0%) |
| Aug 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| May 2013 | - | $0.00 | $0.00 |
FAQ
- What is Zomedica annual cash flow from financing activities?
- What is the all time high annual CFF for Zomedica?
- What is Zomedica annual CFF year-on-year change?
- What is Zomedica quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Zomedica?
- What is Zomedica quarterly CFF year-on-year change?
- What is Zomedica TTM cash flow from financing activities?
- What is the all time high TTM CFF for Zomedica?
- What is Zomedica TTM CFF year-on-year change?
What is Zomedica annual cash flow from financing activities?
The current annual CFF of ZOM is $0.00
What is the all time high annual CFF for Zomedica?
Zomedica all-time high annual cash flow from financing activities is $219.16 M
What is Zomedica annual CFF year-on-year change?
Over the past year, ZOM annual cash flow from financing activities has changed by -$8000.00 (-100.00%)
What is Zomedica quarterly cash flow from financing activities?
The current quarterly CFF of ZOM is -$70.00 K
What is the all time high quarterly CFF for Zomedica?
Zomedica all-time high quarterly cash flow from financing activities is $217.27 M
What is Zomedica quarterly CFF year-on-year change?
Over the past year, ZOM quarterly cash flow from financing activities has changed by -$70.00 K (-100.00%)
What is Zomedica TTM cash flow from financing activities?
The current TTM CFF of ZOM is -$70.00 K
What is the all time high TTM CFF for Zomedica?
Zomedica all-time high TTM cash flow from financing activities is $291.83 M
What is Zomedica TTM CFF year-on-year change?
Over the past year, ZOM TTM cash flow from financing activities has changed by -$70.00 K (-100.00%)